Farnum Rhonda 4
4 · Theravance Biopharma, Inc. · Filed Feb 24, 2026
Insider Transaction Report
Form 4
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Transactions
- Tax Payment
Ordinary Shares
[F1]2026-02-20$19.66/sh−13,929$273,844→ 263,766 total
Footnotes (1)
- [F1]Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.
Signature
/s/ Brett A Grimaud, Attorney-in-Fact|2026-02-24